Merck & Co., Inc.

2008 Annual Report

2008 Chairman's Letter 2008 Form 10-K
Chairman's Letter Financials Board of Directors Corporate Information

BOARD OF DIRECTORS

as of February 1, 2009

Merck's Board of Directors has six standing committees: Audit, Compensation and Benefits, Corporate Governance, Finance, Public Policy and Social Responsibility, and Research. Board members and their committee assignments are listed below.

RICHARD T. CLARK
Chairman, President and Chief Executive Officer, Merck & Co., Inc. Age: 62.
LESLIE A. BRUN
Chairman and Chief Executive Officer, SARR Group, LLC. Non-Executive Chairman, Automatic Data Processing, Inc. Director, Broadridge Financial Solutions, Inc. and Philadelphia Media Holdings, LLC. Merck Director since July 2008. Age: 56. Committees: Audit
JOHNNETTA B. COLE, PH.D.
President Emerita of Spelman College and Bennett College for Women. Merck Director since 1994. Age: 72. Committees: Corporate Governance, Finance, Public Policy and Social Responsibility*
THOMAS H. GLOCER
Chief Executive Officer and Director, Thomson Reuters Corporation. Merck Director since 2007. Age: 49. Committees: Corporate Governance, Compensation and Benefits
STEVEN F. GOLDSTONE
Retired Chairman and Chief Executive Officer, RJR Nabisco, Inc. Managing Partner, Silver Spring Group. Non-Executive Chairman, ConAgra Foods, Inc. Director, Greenhill & Co., Inc. Merck Director since 2007. Age: 63. Committees: Audit, Compensation and Benefits
WILLIAM B. HARRISON, JR.
Retired Chairman of the Board, JPMorgan Chase & Co. Director, Cousins Properties Incorporated and Lincoln Center for the Performing Arts. Merck Director since 1999. Age: 65. Committees: Compensation and Benefits, Corporate Governance, Finance*
HARRY R. JACOBSON, M.D.
Vice Chancellor, Health Affairs, Vanderbilt University. Non-Executive Chairman, CeloNova BioSciences, Inc. Director, HealthGate Data Corporation, Ingram Industries, Inc. and Kinetic Concepts, Inc. Merck Director since 2007. Age: 61. Committees: Public Policy and Social Responsibility, Research
WILLIAM N. KELLEY, M.D.
Professor of Medicine, Biochemistry and Biophysics, University of Pennsylvania School of Medicine. Director, Beckman Coulter, Inc., GenVec, Inc. and Polymedix, Inc. Merck Director since 1992. Age: 69. Committees: Compensation and Benefits, Corporate Governance, Research*
ROCHELLE B. LAZARUS
Chairman, Ogilvy & Mather Worldwide. Director, General Electric. Merck Director since 2004. Age: 61. Committees: Finance, Public Policy and Social Responsibility
THOMAS E. SHENK, PH.D.
Elkins Professor, Department of Molecular Biology, Princeton University. Director, Cell Genesys, Inc. and CV Therapeutics, Inc. Merck Director since 2001. Age: 62. Committees: Audit, Public Policy and Social Responsibility, Research
ANNE M. TATLOCK
Retired Chairman and Chief Executive Officer, Fiduciary Trust Company International. Director, Fortune Brands, Inc. and Franklin Resources, Inc. Merck Director since 2000. Age: 69. Committees: Compensation and Benefits*, Corporate Governance, Finance
SAMUEL O. THIER, M.D.
Professor of Medicine and Health Care Policy, Emeritus, Harvard Medical School. Director, Charles River Laboratories, Inc. Merck Director since 1994. Age: 71. Committees: Corporate Governance*, Public Policy and Social Responsibility, Research
WENDELL P. WEEKS
Chairman and Chief Executive Officer, Corning Incorporated. Director, Corning Incorporated. Merck Director since 2004. Age: 49. Committees: Audit, Corporate Governance, Finance
PETER C. WENDELL
Managing Director, Sierra Ventures. Chairman, Princeton University Investment Company. Merck Director since 2003. Age: 58. Committees: Audit*, Compensation and Benefits, Research
* Indicates Committee Chairperson

 *Software to view files presented in PDF or SWF format is available at no charge through the Adobe Web site. Get Adobe Reader Get Adobe Flash Player

 Copyright © 2009-2010 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.  Privacy  Terms of Use  Sitemap